Page-2 of DCGI

DCGI approves COVID-19 drug to reduce mortality rate

On April 20, 2020, the Drugs Controller General of India (DCGI) approved trial of a drug to reduce mortality rate of COVID-19 patients. Highlights The COVID-19 drug that was developed by the Cadila Pharmaceuticals along with Council of Scientific and ..

Month: 

Drugs and Clinical Trials Rules, 2019

The Union Ministry for Health and Family Welfare has notified the Drugs and Clinical Trials Rules, 2019 with an aim to promote clinical research in the country. Features of the New Rules The new rules reduce the time for approving ..

Month: 

DCGI allows Indian firm to conduct phase 1 trials for Zika vaccine

The Drugs Controller General of India (DCGI) has granted permission to Indian firm to conduct Phase-I clinical trials for a Zika vaccine. It was announced by Union Minister of State (MoS) for Health and Family Welfare Ashwini Kumar Choubey in ..

Month: